Healthequity Inc Stock Price, News & Analysis

HealthEquity (NASDAQ: HQY) has released its second annual Corporate Social Responsibility (CSR) Report, highlighting advancements in ESG efforts and setting measurable goals for future improvement. The report emphasizes the company's commitment to transparency and includes a Materiality Assessment using recognized frameworks like the Global Reporting Initiative and Sustainability Accounting Standards Board. The company aims to enhance workforce diversity and create an inclusive environment, believing such efforts drive innovation and fulfill customer needs.

HealthEquity, Inc. (NASDAQ: HQY) announced the appointment of Rajesh (Nat) Natarajan to its Board of Directors, expanding the Board to 11 members, with 9 being independent. Natarajan brings over 25 years of experience in technology and product strategy, having held senior roles at notable companies like Globalization Partners and RingCentral. His expertise aligns with HealthEquity's growth objectives, focusing on innovation and enhancing product offerings. Chairman Robert Selander expressed confidence in Natarajan's ability to drive growth at HealthEquity, which serves over 14 million accounts.

HealthEquity reported FY22 revenue of $756.6 million, up 3% year-over-year, but incurred a net loss of $44.3 million compared to net income of $8.8 million in FY21. Non-GAAP net income was $110.2 million, down from $127.6 million. The company closed significant acquisitions and increased HSA accounts by 25%, totaling 7.2 million HSAs. The outlook for FY23 anticipates revenues of $820 million to $830 million, with expected net losses between $61 million and $53 million.

HealthEquity, Inc. (NASDAQ: HQY) announced it will report its fiscal year-end financial results on March 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss Q4 and fiscal year results ending January 31, 2022. The company also plans to present virtually at the KeyBank Virtual Life Sciences & Medtech Investor Forum on March 23, 2022. HealthEquity serves over 14 million accounts, focusing on connecting health and wealth.

HealthEquity, Inc. (NASDAQ: HQY) reported significant growth in HSA Assets and Total Accounts for the fiscal year ended January 31, 2022. HSAs increased by 25% to 7.2 million, while Total Accounts rose 12% to 14.4 million. HSA Assets reached $19.6 billion, a 37% increase from the previous year. The company also revised its FY22 revenue guidance to $754-$756 million and provided FY23 guidance of $815-$830 million. Despite a projected net loss between $54 million and $53 million, HealthEquity aims for continued market share growth in the HSA sector.

HealthEquity (HQY), the largest independent health savings account custodian in the U.S., will release its fiscal year-end sales results on February 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET to discuss these results. Management will also attend several investor conferences, including the BTIG Virtual Medtech Conference on February 15, 2022, and the SVB Leerink Annual Global Healthcare Conference on February 16, 2022. A replay of the conference call will be available on the company's investor relations website.

HealthEquity, Inc. (NASDAQ: HQY) reported strong growth for its fiscal year ending January 31, 2022. Estimated HSAs are projected at 7.2 million, up from 5.8 million, and estimated assets reached $19.8 billion, a significant rise from $14.3 billion. Additionally, total accounts are expected to hit around 14.4 million, increasing from 12.8 million. HealthEquity anticipates a yield on HSA cash assets of at least 1.55% for fiscal year 2023. The company plans to discuss these results at the J.P. Morgan Healthcare Conference on January 12, 2022.